SCANTIBODIES Clinical Laboratory begins testing with QuantiFERON®-TB Gold
One Blood Test, One Clear Answer
Scantibodies Laboratory, Inc., our parent company, manufactures several components of the QuantiFERON®-TB Gold kit for Cellestis, Inc. With the development of this revolutionary diagnostic tool, Scantibodies Clinical Laboratory begins testing using the new breakthrough whole blood assay for the detection of latent and active tuberculosis called QuantiFERON®-TB Gold. QuantiFERON®-TB Gold (QFT-G) is a modern alternative to the 100 year-old tuberculin skin test (TST). QFT-G offers unmatched specificity and simplicity providing clinicians with an accurate, reliable and convenient TB diagnostic tool.
QFT-Gold offers compelling advantages over other tests for detection of TB infection and active disease, including:
- Requires only one visit
- Differentiates TB infection from BCG
- Reduces problem of false positive tuberculin skin test (TST) caused by non-tuberculous mycobacteria (NTM)
- Suitable for repeat and serial testing no “booster phenomenon”
- Higher sensitivity (~ 90%) and greater specificity (> 98%) than the tuberculin skin test (TST)
- A simple YES or NO objective in vitro procedure not subject to reader interpretation and bias unlike the TST
- Results are not affected by past positive TST
- FDA Approved
- Recommended by the Centers for Disease Control and Prevention (CDC)
For further information, please contact our Customer Service Department at 866-249-1212 or e-mail: email@example.com
For FAQ, click here !